WHO ICTRP trial
Multi-omics-based exploration of the role and mechanism of the "gut…
ChiCTR2600118142 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR2600118142 |
|---|---|
| Public title | Multi-omics-based exploration of the role and mechanism of the "gut flora-SCFAs-hypothalamus" pathway in the development of post-stroke depression. |
| Scientific title | Multi-omics-based exploration of the role and mechanism of the "gut flora-SCFAs-hypothalamus" pathway in the development of post-stroke depression. |
| Primary sponsor | Affiliated Hospital of Xuzhou Medical University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Observational study |
| Countries | China |
| Conditions | Post-stroke depression |
| Interventions | Post-stroke depression (PSD) group:none;No post-stroke depression group:none |
| Registration date | Feb 2, 2026 |
| Target size | Post-stroke depression (PSD) group:60;No post-stroke depression group:240 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: